For This Insurer, Breathing Now Comes With A Catch
Blue Cross Blue Shield just made it harder for many patients to get vital asthma and allergy medications — all while channeling more profits toward a PBM-affiliated pharmacy.
Health Care
Deep dives into the political corruption and corporate bureaucracy that keeps Americans sick while making executives rich.
Paging Dr. Land Baron
Nonprofit hospitals are building tax-exempt real estate empires — and working to crush politicians who stand in their way.
How To Avoid Asbestos In Your Makeup
Many beauty products include talc, which has been shown to be contaminated with a dangerous toxin. Here’s how to avoid the risk.
The Cover Up Coverup
Warren Buffett’s conglomerate owns a company that profited off a cancer-linked makeup ingredient. Now the firm aims to create a legal precedent — and deny victims remuneration.
YOU LOVE TO SEE IT: Even Trump Doesn’t Trust Big Tech
Google’s monopoly status is questioned, states can sue for climate cleanup, a judge tells Trump to do his research, and a zombie pipeline is stopped in its tracks.
YOU LOVE TO SEE IT: Defrosting The Funding Freeze
Aid money starts to flow, vital youth care is affirmed, a radical housing plan takes root, and desert water gets revolutionized.
Are Hopeful Parents Victims Of A Fertility Scam?
Genetic tests promised parents healthy pregnancies. New class action lawsuits say they may be worthless.
You’ve Already Paid $6 Billion For Weight-Loss Drugs You Can’t Afford
U.S. taxpayers spent billions developing Ozempic-type diabetes and weight-loss drugs — now those drugs’ markups could bankrupt the U.S. health care system.
The Billion-Dollar Taxpayer Math Behind The Ozempic Boom
How Americans spent $6.2 billion to develop overpriced diabetes and weight-loss drugs.
The Hidden Cost Behind Your “$0 Copay” Drug Assistance Program
Copay assistance programs are supposed to reduce drug costs and cover patients’ deductibles — so why are so many people getting stuck with a bill?